Justin Abuel

A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis.

S. Verstovsek, T. George, J. Gotlib, 2019, Blood advances.

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry

M. Triggiani, J. Panse, H. Kluin-Nelemans, 2022, Blood advances.